RecruitingNCT06546943

Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations

Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations (GeM-PEx)

Sponsor

University of Colorado, Denver

Enrollment

50 participants

Start Date

Feb 4, 2022

Study Type

OBSERVATIONAL

Conditions

Cystic Fibrosis Pulmonary Exacerbation

Summary

The goal of this study is to investigate the prevalence of dysglycemia with continuous glucose monitoring (CGM) obtained during pulmonary exacerbations, both outpatient and inpatient, in youth with cystic fibrosis (CF).

Eligibility

Min Age: 6 YearsMax Age: 25 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with cystic fibrosis pulmonary exacerbation. The study is currently recruiting participants at 1 location. People eligible for this study include aged 6 Years to 25 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.